108 related articles for article (PubMed ID: 27957779)
1. Patients with soft tissue sarcoma comprise a higher probability of comorbidities than cancer-free individuals. A secondary data analysis.
Trautmann F; Singer S; Schmitt J
Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 27957779
[TBL] [Abstract][Full Text] [Related]
2. Burden of soft-tissue and bone sarcoma in routine care: Estimation of incidence, prevalence and survival for health services research.
Trautmann F; Schuler M; Schmitt J
Cancer Epidemiol; 2015 Jun; 39(3):440-6. PubMed ID: 25801944
[TBL] [Abstract][Full Text] [Related]
3. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients.
Zagars GK; Ballo MT; Pisters PW; Pollock RE; Patel SR; Benjamin RS; Evans HL
Cancer; 2003 May; 97(10):2530-43. PubMed ID: 12733153
[TBL] [Abstract][Full Text] [Related]
5. High probability of comorbidities in bronchial asthma in Germany.
Heck S; Al-Shobash S; Rapp D; Le DD; Omlor A; Bekhit A; Flaig M; Al-Kadah B; Herian W; Bals R; Wagenpfeil S; Dinh QT
NPJ Prim Care Respir Med; 2017 Apr; 27(1):28. PubMed ID: 28432297
[TBL] [Abstract][Full Text] [Related]
6. Impact of comorbidities on oncological outcomes of Japanese patients with high grade soft tissue sarcomas.
Morii T; Tajima T; Udaka T; Hosogane N; Ichimura S
J Orthop Sci; 2021 Sep; 26(5):878-884. PubMed ID: 32938561
[TBL] [Abstract][Full Text] [Related]
7. Posttraumatic stress disorder and physical comorbidity among female children and adolescents: results from service-use data.
Seng JS; Graham-Bermann SA; Clark MK; McCarthy AM; Ronis DL
Pediatrics; 2005 Dec; 116(6):e767-76. PubMed ID: 16322133
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in soft tissue sarcoma.
Maretty-Nielsen K
Dan Med J; 2014 Nov; 61(11):B4957. PubMed ID: 25370967
[TBL] [Abstract][Full Text] [Related]
9. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and prognostic impact of comorbidity in soft tissue sarcoma: a population-based cohort study.
Maretty-Nielsen K; Aggerholm-Pedersen N; Safwat A; Baerentzen S; Pedersen AB; Keller J
Acta Oncol; 2014 Sep; 53(9):1188-96. PubMed ID: 24588412
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolism in patients with primary bone or soft-tissue sarcomas.
Mitchell SY; Lingard EA; Kesteven P; McCaskie AW; Gerrand CH
J Bone Joint Surg Am; 2007 Nov; 89(11):2433-9. PubMed ID: 17974886
[TBL] [Abstract][Full Text] [Related]
12. Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO).
Valentin T; Le Cesne A; Ray-Coquard I; Italiano A; Decanter G; Bompas E; Isambert N; Thariat J; Linassier C; Bertucci F; Bay JO; Bellesoeur A; Penel N; Le Guellec S; Filleron T; Chevreau C
Eur J Cancer; 2016 Mar; 56():77-84. PubMed ID: 26824706
[TBL] [Abstract][Full Text] [Related]
13. Neurofibromatosis in children with soft tissue sarcoma.
Hartley AL; Birch JM; Marsden HB; Harris M; Blair V
Pediatr Hematol Oncol; 1988; 5(1):7-16. PubMed ID: 3155239
[TBL] [Abstract][Full Text] [Related]
14. [Classification of solid soft tissue tumours by ultrasonography].
Schulte M; von Baer A; Schultheiss M; Scheil-Bertram S
Ultraschall Med; 2010 Apr; 31(2):182-90. PubMed ID: 20306381
[TBL] [Abstract][Full Text] [Related]
15. Monogenic and polygenic determinants of sarcoma risk: an international genetic study.
Ballinger ML; Goode DL; Ray-Coquard I; James PA; Mitchell G; Niedermayr E; Puri A; Schiffman JD; Dite GS; Cipponi A; Maki RG; Brohl AS; Myklebost O; Stratford EW; Lorenz S; Ahn SM; Ahn JH; Kim JE; Shanley S; Beshay V; Randall RL; Judson I; Seddon B; Campbell IG; Young MA; Sarin R; Blay JY; O'Donoghue SI; Thomas DM;
Lancet Oncol; 2016 Sep; 17(9):1261-71. PubMed ID: 27498913
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the British sarcoma referral form.
Smolle MA; Leithner A; Grimer RJ
Ann R Coll Surg Engl; 2015 Sep; 97(6):434-8. PubMed ID: 26274753
[TBL] [Abstract][Full Text] [Related]
17. Statistics of soft-tissue sarcoma in Japan: Report from the Bone and Soft Tissue Tumor Registry in Japan.
Ogura K; Higashi T; Kawai A
J Orthop Sci; 2017 Jul; 22(4):755-764. PubMed ID: 28601416
[TBL] [Abstract][Full Text] [Related]
18. Anxiety disorders and physical comorbidity: increased prevalence but reduced relevance of specific risk factors for hospital-based mortality during a 12.5-year observation period in general hospital admissions.
Schoepf D; Heun R
Eur Arch Psychiatry Clin Neurosci; 2015 Aug; 265(5):387-98. PubMed ID: 25472881
[TBL] [Abstract][Full Text] [Related]
19. Development of an epilepsy-specific risk adjustment comorbidity index.
St Germaine-Smith C; Liu M; Quan H; Wiebe S; Jette N
Epilepsia; 2011 Dec; 52(12):2161-7. PubMed ID: 22004000
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of pretreatment serum C-reactive protein level in soft tissue sarcoma.
Nakamura T; Matsumine A; Matsubara T; Asanuma K; Uchida A; Sudo A
Cancer; 2012 Feb; 118(4):1055-61. PubMed ID: 21761398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
